XM does not provide services to residents of the United States of America.
B
B

Baloise


News

Baloise 9M SST Ratio Of Around 210% As At 30 September

BRIEF-Baloise 9M SST Ratio Of Around 210% As At 30 September Nov 20 (Reuters) - Baloise Holding AG BALN.S : 9M SOLID SST RATIO OF AROUND 210 PER CENT AS AT 30 SEPTEMBER 2024 VOLUME OF BUSINESS IN FIRST NINE MONTHS OF 2024 WAS ON A PAR WITH PRIOR-YEAR PERIOD AT CHF 6,892.0 MILLION HIGH LEVEL OF CASH REMITTANCE OF OVER CHF 550 MILLION EXPECTED NEW FI
B

Zurich forecasts Hurricanes Helene, Milton impact below $360 mln as catastrophe losses rise

UPDATE 2-Zurich forecasts Hurricanes Helene, Milton impact below $360 mln as catastrophe losses rise Adds background in paragraph 2, CFO comment 3, 8, CEO 9, shares 10 By Carolyn Cohn LONDON, Nov 7 (Reuters) - Zurich Insurance Group ZURN.S said on Thursday that its exposure to Hurricanes Helene and Milton, which recently wreaked havoc in the United States, would be less than $360 million, as insurers face increasing losses from natural catastrophes.
B
Z

Elisa, Nexus, Telia

EUROPE RESEARCH ROUNDUP-Elisa, Nexus, Telia Nov 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Elisa, Nexus and Telia on Wednesday. HIGHLIGHTS * Elisa Oyj ELISA.HE : Barclays raises to overweight from underweight * Inficon Holding AG IFCN.S : Berenberg raises to buy from hold * Nexus AG NXUG.DE : Stifel cuts to hold from buy * Telenor ASA TEL.OL : Barclays cuts to equal weight from overweight * Telia TELIA.ST : Barclays cuts to u
3
A
A
A
B
B
B
B
C
D
D
E
E
H
H
H
T
T
T
A
B
F
R
S

Baloise: Thomas Schöb New CEO Of Baloise Bank Ltd

BRIEF-Baloise: Thomas Schöb New CEO Of Baloise Bank Ltd Nov 5 (Reuters) - Baloise Holding AG BALN.S : BALOISE HOLDING AG - BALOISE BANK LTD WILL BE UNDER NEW MANAGEMENT FROM 1 JANUARY 2025. AT HIS OWN REQUEST, JÜRG RITZ IS HANDING OVER CEO BATON TO THOMAS SCHÖB Further company coverage: BALN.S (Gdansk Newsroom)
B

Baloise Sells Friday Portfolio

BRIEF-Baloise Sells Friday Portfolio Oct 29 (Reuters) - Baloise Holding AG BALN.S : SELLS FRIDAY PORTFOLIO PARTIES HAVE AGREED NOT TO DISCLOSE PURCHASE PRICE WE ANTICIPATE A ONE-OFF NEGATIVE IMPACT ON EARNINGS OF AROUND CHF 75 MILLION, MOST OF WHICH WILL BE RECOGNISED IN 2024 Further company coverage: BALN.S (Gdansk Newsroom) ;))
B

Top of the Street: Ubisoft, Swiss insurers

BUZZ-Top of the Street: Ubisoft, Swiss insurers A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** HSBC downgrades French video game maker Ubisoft UBIP.PA to "hold" from "buy" and cuts PT by 66% to EUR 10.8, citing Wednesday's profit warning and execution risks, and says there remain risks to earnings in the near term INITIATIONS AND REINSTATEMENTS ** Deutsche Bank initiates Baloise BALN.S with "buy", Helvetia HSPF.S with "hold" and Swiss Life SLHN.S with "
B
D
H
U
S

Big Technologies, Safran, Volution Group

EUROPE RESEARCH ROUNDUP-Big Technologies, Safran, Volution Group Sept 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Big Technologies, Safran and Volution Group on Friday. HIGHLIGHTS * 3I Group III.L : Citigroup raises target price to 4140p from 3850p * Big Technologies Plc BIGB.L : Peel Hunt raises to add from hold * Safran SAF.PA : Jefferies raises target price to EUR 220 from EUR 205 * Solar Foods Oyj SFOODS.HE : Inderes rai
3
A
A
B
B
C
D
F
H
L
S
S
S
S
T
U
H
A
F
S

Burberry, Experian, GEA Group

EUROPE RESEARCH ROUNDUP- Burberry, Experian, GEA Group Sept 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Burberry, Experian and GEA Group, on Thursday. HIGHLIGHTS * Burberry BRBY.L : RBC cuts target price to 650p from 800p * Experian EXPN.L : RBC raises to sector perform from underperform * FACC AG FACC.VI : Kepler Cheuvreux raises to buy from hold * GEA Group AG G1AG.DE : Morgan Stanley raises to overweight from equal-weight
B
B
B
E
E
G
H
K
K
L
M
P
R
S
S
U
U
P

JPM says strong non-life businesses justify Swiss insurers' premium valuations

BUZZ-JPM says strong non-life businesses justify Swiss insurers' premium valuations ** J.P.Morgan says Swiss insurers' valuation premiums vs European peers are justified, as their high-quality non-life and fee-based products have ensured strong margins, attractive cash flow and growth over the past decade ** That has offset slower growth in their l
B
H
S

Air France-KLM, Burberry, Wise

EUROPE RESEARCH ROUNDUP- Air France-KLM, Burberry, Wise Sept 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air France-KLM, Burberry and Wise, on Wednesday. HIGHLIGHTS * Air France-KLM AIRF.PA : JP Morgan raises to overweight from underweight * Burberry BRBY.L : JP Morgan cuts target price to 650p from 800p * Helvetia Holding HELN.S : JP Morgan places stock on its positive catalyst watch list * Orion Oyj ORNBV.HE : Jefferies ra
A
B
B
B
B
B
E
H
H
K
K
A
J
S

Swiss stocks - Factors to watch on September 25

Swiss stocks - Factors to watch on September 25 ZURICH/GDANSK, Sept 25 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS LECLANCHE SA LECN.S and Pinnacle will establish a joint venture company funded by pinnacle for an amount of up to 360 million Swiss francs. ANALYSTS' VIEWS HELVETIA HOLDING AG HELN.S - JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE CHF 170; PLACES STOCK ON ITS POSITIVE CATALYST WATCH LIST SWISS LIFE H
B
H
S

Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies

BUZZ-Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies ** Vontobel estimates the market potential for obesity drugs in the U.S. to reach a three-digit billion U.S. dollar amount and picks Swiss Re SRENH.S and Ypsomed YPSN.S as the most likely to profit from it ** Among Swiss life insurers, Swiss Re could benefit the most from a rising demand in life and health reinsurance, with a market share of about 15%, as obesity drugs improve life expectancy, it says ** Its posit
B
H
N
R
S
S
Z

MTU Aero Engines, Nestle, Vusiongroup

EUROPE RESEARCH ROUNDUP- MTU Aero Engines, Nestle, Vusiongroup Sept 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including MTU Aero Engines, Nestle and Vusiongroup, on Monday. HIGHLIGHTS * Advanced Medical Solutions Group Plc AMSU.L : Peel Hunt raises target to 246p from 220p * MTU Aero Engines AG MTXGn.DE : Citigroup cuts to sell from neutral * Nestle SA NESN.S : Morgan Stanley cuts to underweight from equal-weight * Sodexo EXHO.PA : B
A
A
B
B
C
D
I
I
M
M
N
N
S
A
A
P

Swiss stocks - Factors to watch on September 16

Swiss stocks - Factors to watch on September 16 ZURICH/GDANSK, Sept 16(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: SOFTWAREONE HOLDING SWON.S Swiss technology firm was exploring a potential merger with smaller Norwegian competitor Crayon Group Holding CRAYN.OL , Bloomberg News reported on Friday, citing people familiar with the matter.
B

Baloise's new strategy not bold enough, say investors

Baloise's new strategy not bold enough, say investors By Oliver Hirt ZURICH, Sept 13 (Reuters) - Investors in Baloise BALN.S say the Swiss insurer's plans to shake up its business with bigger returns to shareholders and job cuts are unlikely to be enough to satisfy the market, and it may end up having to sell parts of its business. Baloise unveiled its strategy on Thursday and said it could also consider share buybacks next year.
B

Activist investor Cevian unimpressed by Baloise proposals

Activist investor Cevian unimpressed by Baloise proposals ZURICH, Sept 12 (Reuters) - Activist investor Cevian on Thursday said it was unimpressed by Baloise's proposals BALN.S to improve performance at the Swiss insurer. "For Baloise to become a great Swiss insurance company, real focus and real ambition are needed," said Cevian partner Robert Schuchna.
B

Baloise eyeing changes in board of directors, chairman says

UPDATE 1-Baloise eyeing changes in board of directors, chairman says Adds details throughout By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Baloise eyeing changes in board of directors, chairman says

Baloise eyeing changes in board of directors, chairman says ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Swiss insurer Baloise targets higher shareholder returns after Cevian move

UPDATE 5-Swiss insurer Baloise targets higher shareholder returns after Cevian move Baloise to boost return on equity, cut jobs, considers buybacks CEO emphasizes efficiency and core business performance Chairman says board changes under consideration Adds comment from Cevian, paragraphs 2, 6-7 By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity, cut jobs and will consider share buybacks after Swedish activist investor Cevia
B

Baloise targets higher returns for shareholders after Cevian move

Baloise targets higher returns for shareholders after Cevian move ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity and will consider share buybacks after activist investor Cevian Capital this week revealed it held over 9% of the company's stock, becoming its top stakeholder. Baloise said in a statement that its new targets include a return on equity of 12% to 15%, cash remittance of more than 2 billion Swiss francs ($2.34 billion) in th
B



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.